12:00 AM
 | 
Oct 15, 2012
 |  BC Week In Review  |  Company News  |  Deals

Mucosis, J&J deal

Mucosis granted Crucell N.V. rights to use Mimopath technology to develop vaccines against infectious diseases. The technology is based...

Read the full 83 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >